Home/ Supplements/ Collagen/ Extreme Flex

Extreme Flex

product on market Capsule KingFisher Media Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines collagen, MSM, and turmeric derivatives to support joint health and inflammation. Research provides moderate evidence that these ingredients may reduce joint discomfort and improve mobility. However, the overall evidence coverage for this specific ingredient profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Extreme Flex
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
17%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Perluxan(R) Hops extract
500 mg
Market median: 20.0mg (931 products) 234 studies (A:1, B:90)
Regenasure
250 mg
OptiMSM
125 mg
Turmipure(R)
50 mg
UC-II(R)
20 mg

Other Ingredients

Magnesium Stearate FD&C Blue #1 FD&C Yellow #5 FD&C Yellow #6 Titanium Dioxide Gelatin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Warnings & Precautions

PRECAUTIONS: Use only as directed.

Do not take this product if you are pregnant or nursing. Consult a health care professional before use if you are allergic to any ingredients, have a serious medical condition, or use prescription medications.

Consult a health care professional before use if you are allergic to any ingredients, have a serious medical condition, or use prescription medications.

For adult use only.

Formulation Notes

It utilizes the revolutionary ingredient UC-II(R), which is 2x stronger than Glucosamine and Chondroitin - common ingredients in joint formulas.

Extreme Flex(TM) also contains Perluxan(R), working as an all-natural equivalent to ibuprofen for temporary relief of minor pain++.

Additional Information

FLEXIBILITY- MOBILITY - RECOVERY

INCREASE MOBILITY - JOINT RELIEF & RECOVERY

ALL NATURAL EQUIVALENT TO IBUPROFEN FOR TEMPORARY RELIEF OF MINOR PAIN++

RELIEF IN AS LITTLE AS 3 DAYS!* RESULTS MAY VARY.

USAGE: As a dietary supplement, Take one (1) serving (2) capsules daily. For temporary relief of minor pain: Take two (2) servings - (4) capsules daily.

UC-II(R)

BioCell Collagen(TM)

perluxan

Regenasure(R) GLUCOSAMINE

++DSHEA Approved Claim

Made in USA

GOOD MANUFACTURING PRACTICE MANUFACTURED IN A GMP CERTIFIED FACILITY QUALITY GUARANTEED

kingfisher media

2X STRONGER THAN GLUCOSAMINE & CHONDROITIN+

Metadata

Product Details

DSLD Entry Date2015-02-25
Product TypeOther Combinations
FormCapsule
DSLD ID42133
Data Updated2026-04-11
Research

Research Evidence

281
Research Sources
54
Avg Quality
141
Meta Analysis
72
Systematic Review
45
Rct
18
Clinical Trial
2
Narrative Review
1
Other
1
Guideline
1
Openfda Safety
A Vascular closure devices for femoral arterial puncture site haemostasis
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2023 PubMed DOI
B Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Bisphosphonate therapy for osteogenesis imperfecta
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Punctal occlusion for dry eye syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Dressings and topical agents containing hyaluronic acid for chronic wound healing
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
B Efficacy of statins for osteoporosis: a systematic review and meta-analysis
Meta Analysis Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2017 PubMed DOI
B Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
B Bisphosphonate therapy for osteogenesis imperfecta
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Bisphosphonates for osteoporosis in primary biliary cirrhosis
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
View all evidence for Collagen →
Compare

Similar Products

View all Collagen products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.